» Authors » H Danafar

H Danafar

Explore the profile of H Danafar including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 4
Citations 58
Followers 0
Related Specialties
Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Danafar H, Manjili H, Najafi M
Drug Res (Stuttg) . 2016 Jul; 66(9):495-504. PMID: 27434113
Enalapril was used for hypertension and congestive heart failure. Di-block mPEG-PCL copolymers were synthesized and used to prepare of polymersomes for controlled release of enalapril as a hydrophilic drug. The...
2.
Danafar H
Drug Res (Stuttg) . 2016 Jul; 66(10):506-519. PMID: 27403578
Nanoparticles have outstanding compensate compared with other drug carriers, as a result of their small particle size and bulky and changeable surface. Recently, block copolymers have get imaginary movement on...
3.
Danafar H, Rostamizadeh K, Davaran S, Hamidi M
Pharm Dev Technol . 2016 Jan; 22(8):947-957. PMID: 26740008
A conjugate of the antihypertensive drug, lisinopril, with triblock poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) copolymer was synthesized by the reaction of PLA-PEG-PLA copolymer with lisinopril in the presence of dicyclohexylcarbodiimide...
4.
Danafar H, Rostamizadeh K, Davaran S, Hamidi M
Drug Dev Ind Pharm . 2013 Aug; 40(10):1411-20. PMID: 23944838
Tri-block poly(lactide)-poly(ethylene glycol)-poly(lactide) (PLA-PEG-PLA) copolymers were synthesized and used to prepare polymersomes loaded separately by the hydrophobic and hydrophilic model drugs, atorvastatin and lisinopril, respectively. The resulting nanostructures were characterized...